288 related articles for article (PubMed ID: 30539729)
21. Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast.
Dickson BC; Hornick JL; Fletcher CDM; Demicco EG; Howarth DJ; Swanson D; Zhang L; Sung YS; Antonescu CR
Genes Chromosomes Cancer; 2018 Sep; 57(9):437-445. PubMed ID: 30014607
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease.
McArthur GA
J Natl Compr Canc Netw; 2007 May; 5(5):557-62. PubMed ID: 17509258
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma Protuberans.
Reha J; Katz SC
Surg Clin North Am; 2016 Oct; 96(5):1031-46. PubMed ID: 27542641
[TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
25. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract][Full Text] [Related]
26. Dermatofibrosarcoma Protuberans.
Acosta AE; Vélez CS
Curr Treat Options Oncol; 2017 Aug; 18(9):56. PubMed ID: 28795284
[TBL] [Abstract][Full Text] [Related]
27. Orbital dermatofibrosarcoma protuberans with intracranial extension preceded by recurrent leiomyoma of the orbit: a case report.
Bashir S; Tariq M; Aslam HM; Hashmi AS; Malik B; Amin A; Mumtaz S
J Med Case Rep; 2015 Apr; 9():96. PubMed ID: 25924890
[TBL] [Abstract][Full Text] [Related]
28. Malignant fibrous tumors.
Stadler FJ; Scott GA; Brown MD
Semin Cutan Med Surg; 1998 Jun; 17(2):141-52. PubMed ID: 9669607
[TBL] [Abstract][Full Text] [Related]
29. [Dermatofibrosarcoma: Management].
Penel N; El Bedoui S; Robin YM; Decanter G
Bull Cancer; 2018 Nov; 105(11):1094-1101. PubMed ID: 30297237
[TBL] [Abstract][Full Text] [Related]
30. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
[TBL] [Abstract][Full Text] [Related]
31. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
32. [Dermatofibrosarcoma protuberans : clinico-pathological aspects and management].
Grizzetti L; Gaide O; Kuonen F
Rev Med Suisse; 2020 Apr; 16(688):640-645. PubMed ID: 32239838
[TBL] [Abstract][Full Text] [Related]
33. [Perianal dermatofibrosarcoma protuberans: a case report, review and update].
Velasco Albendea FJ; Doña Girón J; Blanco Villar ML; Vallejo Benítez A; Álvarez García AF
Rev Esp Patol; 2019; 52(1):62-68. PubMed ID: 30583835
[TBL] [Abstract][Full Text] [Related]
34. [Dermatofibrosarcoma protuberans].
Ugurel S
Hautarzt; 2008 Nov; 59(11):933-9; quiz 940. PubMed ID: 18936902
[TBL] [Abstract][Full Text] [Related]
35. Dermatofibrosarcoma protuberans: a surgical disease with a molecular savior.
McArthur GA
Curr Opin Oncol; 2006 Jul; 18(4):341-6. PubMed ID: 16721128
[TBL] [Abstract][Full Text] [Related]
36. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
[TBL] [Abstract][Full Text] [Related]
37. [Dermatofibrosarcoma protuberans. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
Breuninger H
Hautarzt; 1998 Oct; 48 Suppl 1():S46-8. PubMed ID: 9866048
[No Abstract] [Full Text] [Related]
38. Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report.
McGee MW; Boukhar SA; Monga V; Weigel R; Phadke SD
J Med Case Rep; 2019 Dec; 13(1):374. PubMed ID: 31852518
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract][Full Text] [Related]
40. Review of dermatofibrosarcoma protuberans.
Lim SX; Ramaiya A; Levell NJ; Venables ZC
Clin Exp Dermatol; 2023 Mar; 48(4):297-302. PubMed ID: 36630365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
